Study Stopped
Due to a business decision to stop the project, the study was terminated early.
An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths
A Double-blind, Randomized, Controlled Evaluation of the Tolerability of a Proprietary Oil Blend in Adults Residing in Areas Endemic for Helminth Infections.
1 other identifier
interventional
45
1 country
1
Brief Summary
The prevalence of intestinal helminths is worldwide. This study will evaluate the tolerability of a novel food product consumed by adults residing in an area endemic for helminths.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 3, 2011
CompletedFirst Posted
Study publicly available on registry
January 6, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedDecember 12, 2012
December 1, 2012
1.1 years
January 3, 2011
December 11, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Measure of Safety and Tolerability using the Reactogenicity Questionairre
Reactogenicity will be assessed using a structured questionnaire on days 2, 14, 28, and 42 of the study. In addition, blood will be collected on study days 14 and 42 for assessment of basic hematologic and clinical chemistry parameters.
43 days
Study Arms (2)
Control Food Product
PLACEBO COMPARATORConsumption of placebo food product
Novel Food Product
EXPERIMENTALConsumption of novel food product
Interventions
Eligibility Criteria
You may qualify if:
- Healthy Male or Female adults, age 18-45 years old inclusive on date of screening
- Showing presence of no or mild-moderate helminths
You may not qualify if:
- Presence of heavy helminth load
- Pregnant or lactating
- Hepatosplenomegaly or clinically significant abnormal hemoglobin, LAT or creatinine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mondelēz International, Inc.lead
- TyraTech Technologycollaborator
Study Sites (1)
Centro de Pesquisas Rene Rachou-FIOCRUZ
Minas Gerais, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Diemert, MD, FRCP(C)
Rene Rachou Research Center, Brazil
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2011
First Posted
January 6, 2011
Study Start
January 1, 2011
Primary Completion
February 1, 2012
Study Completion
February 1, 2012
Last Updated
December 12, 2012
Record last verified: 2012-12